Usana Health Sciences

USNA

Source: the SEC Form 13F filings of the managers we follow, latest for Q2 2026. How we use them

Value held

$25.7m

Combined value at quarter end

Last quarter

1 bought

0 sold or trimmed

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Usana Health Sciences

Pzena Investment Management	0.1%$25.7m	$25.7m	Added +8.7%	20 qtrs

Download the holders: CSV · JSON · Markdown

About the company

Sector: Health care · Medicinal Chemicals & Botanical Products
Incorporated in: Utah
Financial year ends: 3 January
Shares outstanding: 18m at 11 Aug 2026
SEC filings: Annual reports and other filings on EDGAR

Revenue and profit

2013

2014

2015

$1.0bn2016

$1.1bn2020

$1.2bn2021

$999m2022

$921m2023

$855m2024

$925m2025

Usana Health Sciences revenue and net income by year
Year	Revenue	Net income
2025	$925m	$10.8m
2024	$855m	$42.0m
2023	$921m	$63.8m
2022	$999m	$69.3m
2021	$1.2bn	$117m
2020	$1.1bn	$125m
2016	$1.0bn	–
2015	–	$94.7m
2014	–	$76.6m
2013	–	$79.0m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

Usana Health Sciences

Managers holding it, by quarter

Who holds it

About the company

Revenue and profit